Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection
- PMID: 14978118
- DOI: 10.4049/jimmunol.172.5.3119
Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection
Abstract
Cytokines and chemokines activate and direct effector cells during infection. We previously identified a functional group of five cytokines and chemokines, namely, IFN-gamma, activation-induced T cell-derived and chemokine-related cytokine/lymphotactin, macrophage-inflammatory protein 1alpha, macrophage-inflammatory protein 1beta, and RANTES, coexpressed in individual activated NK cells, CD8(+) T cells, and CD4(+) Th1 cells in vitro and during in vivo infections. However, the stimuli during infection were not known. In murine CMV (MCMV) infection, the DAP12/KARAP-associated Ly49H NK cell activation receptor is crucial for resistance through recognition of MCMV-encoded m157 but NK cells also undergo in vivo nonspecific responses to uncharacterized stimuli. In this study, we show that Ly49H ligation by m157 resulted in a coordinated release of all five cytokines/chemokines from Ly49H(+) NK cells. Whereas other cytokines also triggered the release of these cytokines/chemokines, stimulation was not confined to the Ly49H(+) population. At the single-cell level, the production of the five mediators showed strong positive correlation with each other. Interestingly, NK cells were a major source of these five cytokines/chemokines in vitro and in vivo, whereas infected macrophages produced only limited amounts of macrophage-inflammatory protein 1alpha, macrophage-inflammatory protein1beta, and RANTES. These findings suggest that both virus-specific and nonspecific NK cells play crucial roles in activating and directing other inflammatory cells during MCMV infection.
Similar articles
-
Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.J Immunol. 2004 Nov 15;173(10):6312-8. doi: 10.4049/jimmunol.173.10.6312. J Immunol. 2004. PMID: 15528370
-
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense.J Clin Invest. 2000 Apr;105(7):985-93. doi: 10.1172/JCI9232. J Clin Invest. 2000. PMID: 10749577 Free PMC article.
-
Specific and nonspecific NK cell activation during virus infection.Nat Immunol. 2001 Oct;2(10):951-6. doi: 10.1038/ni714. Nat Immunol. 2001. PMID: 11550009
-
Calling in the troops: regulation of inflammatory cell trafficking through innate cytokine/chemokine networks.Viral Immunol. 2003;16(3):291-306. doi: 10.1089/088282403322396109. Viral Immunol. 2003. PMID: 14583145 Review.
-
Cytokine and chemokine networks: pathways to antiviral defense.Curr Top Microbiol Immunol. 2006;303:29-46. doi: 10.1007/978-3-540-33397-5_2. Curr Top Microbiol Immunol. 2006. PMID: 16570855 Review.
Cited by
-
Natural killer cells as an initial defense against pathogens.Curr Opin Immunol. 2006 Aug;18(4):391-8. doi: 10.1016/j.coi.2006.05.002. Epub 2006 Jun 12. Curr Opin Immunol. 2006. PMID: 16765573 Free PMC article. Review.
-
NK cell development, homeostasis and function: parallels with CD8⁺ T cells.Nat Rev Immunol. 2011 Aug 26;11(10):645-57. doi: 10.1038/nri3044. Nat Rev Immunol. 2011. PMID: 21869816 Free PMC article. Review.
-
TP53 Mutations Promote Immunogenic Activity in Breast Cancer.J Oncol. 2019 Jun 2;2019:5952836. doi: 10.1155/2019/5952836. eCollection 2019. J Oncol. 2019. PMID: 31275382 Free PMC article.
-
The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation.J Exp Med. 2008 Sep 29;205(10):2419-35. doi: 10.1084/jem.20072327. Epub 2008 Sep 22. J Exp Med. 2008. PMID: 18809712 Free PMC article.
-
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets.Blood. 2010 Jan 14;115(2):274-81. doi: 10.1182/blood-2009-04-215491. Epub 2009 Nov 6. Blood. 2010. PMID: 19897577 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials